Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$106M |
| 2 |
NXP Semiconductors
NXPI
|
+$93.6M |
| 3 |
Alibaba
BABA
|
+$90M |
| 4 |
ExxonMobil
XOM
|
+$83.7M |
| 5 |
Charter Communications
CHTR
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$162M |
| 2 |
B
Barrick Mining
B
|
+$156M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$144M |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$65.4M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.13% |
| 2 | Technology | 14.52% |
| 3 | Consumer Staples | 10.68% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Seaboard Corp
SEB
$4.08B
| $1.35M | ﹤0.01% |
472
+9
| +2% | +$26.4K |
|
|
SAVE
1777
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.35M | ﹤0.01% |
30,200
-600
| -2% | -$26.7K |
|
|
IPHS
1778
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.35M | ﹤0.01% |
32,100
-1,100
| -3% | -$41.3K |
|
|
BBT
1779
Beacon Financial Corp
BBT
$2.71B
| $1.35M | ﹤0.01% |
50,300
+3,200
| +7% | +$86K |
|
1780
AAR Corp
AIR
$5.77B
| $1.35M | ﹤0.01% |
57,700
| – | – |
|
|
VIVO
1781
DELISTED
Meridian Bioscience Inc
VIVO
| $1.35M | ﹤0.01% |
69,000
+1,700
| +3% | +$33.3K |
|
1782
Puma Biotechnology
PBYI
$450M
| $1.34M | ﹤0.01% |
45,130
| – | – |
|
|
AMAG
1783
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.34M | ﹤0.01% |
56,157
| – | – |
|
1784
Hanmi Financial
HAFC
$963M
| $1.34M | ﹤0.01% |
57,100
+1,400
| +3% | +$32.1K |
|
1785
Qualys
QLYS
$6.78B
| $1.34M | ﹤0.01% |
45,000
+5,900
| +15% | +$166K |
|
|
VRTU
1786
DELISTED
Virtusa Corporation
VRTU
| $1.34M | ﹤0.01% |
46,400
| – | – |
|
|
TDAY
1787
USA Today Co
TDAY
$1B
| $1.34M | ﹤0.01% |
74,062
+4,400
| +6% | +$72.5K |
|
|
BRKL
1788
DELISTED
Brookline Bancorp
BRKL
| $1.33M | ﹤0.01% |
121,000
+2,700
| +2% | +$30.2K |
|
|
TBI
1789
Trueblue
TBI
$309M
| $1.33M | ﹤0.01% |
70,500
+1,500
| +2% | +$31.3K |
|
|
SAFE
1790
Safehold
SAFE
$1.1B
| $1.33M | ﹤0.01% |
28,536
-2,095
| -7% | -$98.6K |
|
|
CSR
1791
Centerspace
CSR
$939M
| $1.33M | ﹤0.01% |
20,540
| – | – |
|
|
LMNX
1792
DELISTED
Luminex Corp
LMNX
| $1.33M | ﹤0.01% |
65,600
+1,300
| +2% | +$26K |
|
|
SPNC
1793
DELISTED
Spectranetics Corp
SPNC
| $1.32M | ﹤0.01% |
70,800
+1,700
| +2% | +$29.9K |
|
1794
Supernus Pharmaceuticals
SUPN
$2.74B
| $1.32M | ﹤0.01% |
65,000
+8,700
| +15% | +$154K |
|
|
NCI
1795
DELISTED
Navigant Consulting, Inc.
NCI
| $1.32M | ﹤0.01% |
82,000
| – | – |
|
|
UNT
1796
DELISTED
UNIT Corporation
UNT
| $1.32M | ﹤0.01% |
84,900
+5,800
| +7% | +$76.9K |
|
|
KYNB
1797
Kyntra Bio
KYNB
$28.5M
| $1.31M | ﹤0.01% |
3,200
| – | – |
|
1798
Central Pacific Financial
CPF
$1B
| $1.31M | ﹤0.01% |
55,600
+7,000
| +14% | +$160K |
|
|
DENN
1799
DELISTED
Denny's
DENN
| $1.31M | ﹤0.01% |
122,300
-6,300
| -5% | -$66.5K |
|
|
HIBB
1800
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.31M | ﹤0.01% |
37,700
-1,700
| -4% | -$58.9K |
|
Similar funds
Swiss National Bank's Q2 2016 Portfolio in Review
As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.
- Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
- Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
- Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
- Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
- Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
- Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
- Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.
Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.